Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ARMK trades at $54.94, down about 1% on the week and 4.6% over the past month, yet the Street has spent recent months aggressively lifting its price targets. That gap between where the stock is and where analysts think it should be is the central tension heading into November's earnings report.
The analyst community swung firmly into buy mode after August's quarterly results. JP Morgan raised its target from $55 to $70, RBC Capital lifted from $60 to $70, Citigroup moved to $74, and Stifel, Jefferies, UBS and Baird all raised targets into the $69 to $71 range. Every recent change was a raise with no downgrades. The consensus mean target now sits at $68.50, implying roughly 25% above the current price. The bull case is built on record net-new business of $1 billion year-to-date, retention above 98%, margin expansion from productivity gains and falling leverage approaching 3x, plus a growing data-center services opportunity that management has framed as a potential $3 to $4 billion revenue addition by end-2028. Bears push back on food and wage inflation risk, the cyclical sensitivity of the end markets, and remaining leverage. These analyst target raises are now nearly two months old, and the stock has given back ground since then, so the degree of conviction behind those numbers will be tested at the November 17 print.
Short positioning tells a relaxed story. Short interest has been drifting lower for weeks, from roughly 9 million shares in mid-September to about 8.1 million now, leaving it at just 3.1% of free float. Borrowing conditions are equally loose: cost to borrow is less than 0.5% and availability is at 7,301%, meaning there are approximately 73 shares available to borrow for every one currently lent out. There is no squeeze dynamic, no meaningful borrow constraint, and no sign that bears are building a serious position. The ORTEX short score of 34.6 sits in the lower half of the universe, consistent with this picture. Options positioning is mild too, with the put/call ratio at 0.87, just above its 20-day average of 0.83 and less than one standard deviation from that mean. Taken together, the market's stated bearish conviction is close to absent.
The factor picture reinforces the constructive analyst view on earnings quality. EPS momentum scores rank in the 92nd to 93rd percentile over both 30- and 90-day horizons, and the forward EPS year-on-year increase ranks in the 96th percentile across the ORTEX universe. Those numbers reflect the scale of the earnings revisions that followed August's report. Value remains the weak spot: EV/EBITDA is near 10x and the EV/EBIT factor scores in the 27th percentile, consistent with the bear case argument that the stock prices in a lot of the margin recovery already.
On the ownership side, BlackRock holds 9.4% of shares and recently added to its position, reporting a 391,556-share increase. T. Rowe Price added 762,040 shares in its latest reporting period. There are no activist 13D holders on the register, all filings are passive 13G disclosures, and stakes are as-last-disclosed around the 5% threshold. On the insider side, October 2 saw a cluster of Form F transactions, the tax-withholding code associated with share vesting, from CEO John Zillmer, CFO James Tarangelo, the General Counsel, COO and Chief HR Officer simultaneously. These are compensation mechanics tied to a vesting event, not open-market sales, and carry limited signal on their own. There have been no open-market purchases by insiders in the reported window.
The November 17 earnings date is the next clear reference point. The last two prints have had notably different outcomes: August 2026 produced an 8.3% one-day gain that held through the week, while the prior report moved less than 0.3% on the day before rallying around 6.5% over the following five sessions. The question into the next print is whether the data-center pipeline, the net-new business momentum and the margin trajectory can keep pace with a set of analyst estimates that have moved considerably higher since August.
See the live data behind this article on ORTEX.
Open ARMK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
